The low P/E ratio of Guilin Sanjin Pharmaceutical may be due...
The low P/E ratio of Guilin Sanjin Pharmaceutical may be due to investors' expectations of limited future growth. Unless the company's earnings outlook improves, the low P/E ratio could continue to limit the stock's price.
Guilin Sanjin Pharmaceutical Co., Ltd. (SZSE:002275) Looks Inexpensive But Perhaps Not Attractive Enough
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment